Significant differences were observed between the CHB + MAFLD and CHB groups in terms of male proportion, history of diabetes mellitus, history of cirrhosis, body mass index (BMI), ratio of overweight/obesity individuals, CAP values, and proportion of elevated ALT (P < 0.05). The gene discussed is GPT; the disease is Cirrhosis.